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IMPLANT CONDUCTOR ASSEMBLY WITH IMPROVED RADIO 
FREQUENCY PROPERTIES 
Field of the Invention 
5 This invention relates to an implant conductor assembly with improved radio 
frequency properties. Preferably the invention may be used to minimise the 
induction of radio frequency currents within an electrode lead of an implant 
conductor assembly.  
10 Background of the Invention 
A variety of therapeutic devices have been developed to deliver bioelectrical 
stimulation therapies. These devices are surgically implanted into the body 
of a patient and normally incorporate control electronics connected to a 
power supply system such as a battery pack. As these components can be 
15 relatively large they may be sited within a user's body some distance from 
an organ, muscle or structure requiring bioelectrical stimulation. An implant 
electrode lead commonly needs to be run through the body from the power 
and control electronics to the region requiring bioelectrical stimulation.  
20 Surgical implant manufacturers select implant conductors which exhibit low 
electrical resistance to direct currents. This selection minimises the voltage 
required to generate therapeutic currents while also maximising implant 
battery lifespans.  
25 However, the presence of surgical implants creates a patient safety issue 
with the use of Magnetic Resonance Imaging (MRI) machines. The operation 
of MRI scanning machines involves: 
SA large magnetic field, 
30 A varying magnetic field in the kilohertz range which induces eddy 
currents, 
• An RF field operating at the 50-250 megahertz range.  
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MRI machines are carefully designed and used under strict operational 
protocols to avoid inadvertent heating of patient body tissues. The high 
frequency RF field can produce longitudinal electrode lead currents at RF 
frequencies which result in heating effects in the lead conductors and the 
5 electrodes.  
Surgically implanted conductors act as antennas within the body and 
concentrate the strong radio frequency fields generated by an MRI machine.  
This can result in high temperatures at the electrode end of the implant as 
10 its lead is exposed to the MRI field. This is a significant patient safety 
problem when the length of the implant conductor is approximately equal to 
an odd integer multiple of the half wavelength at the electric field frequency 
- for example - A/2, 3A/2, 5A/2 etc.  
15 One attempt to address these problems with implant leads and MRI 
machines is disclosed in United States Patent no. US 8364286. This 
document describes an implant lead assembly which employs a Faraday 
shield to surround and encapsulate an implant electrode lead. This 
technology aims to shield the electrode lead from local electromagnetic fields 
2o and thereby decrease the heating effects experienced by the lead.  
However, the size and dimensions of implant conductor assemblies cause 
manufacturing complications for the technology described above. In 
particular, these forms of electrode lead shields must be formed on the same 
25 small scale as the electrode leads used and must fully enclose and wrap 
closely around the electrode lead to function effectively. These requirements 
therefore make the resulting implant conductor assembly difficult and 
expensive to manufacture.  
30 It would therefore be of advantage to have available an improved implant 
conductor technology which addressed or mitigated the above problems, or 
at the very least provided an alternative choice over the current prior art. It 
would be of particular advantage to have an inexpensive implant conductor 
assembly with improved radio frequency properties targeted at minimising 
35 the induction of radio frequency currents within an implant conductor 
electrode lead.  
2
Disclosure of the Invention 
According to one aspect of the present invention there is provided an 
5 implant conductor lead assembly which includes an electrode lead 
comprising at least one length of conductive material, and at least one field 
target conductor located adjacent to the electrode lead such that a 
longitudinal axis of the or each field target conductor is offset from a 
longitudinal axis of the electrode lead, the at least one field target conductor 
o being located to mutually couple the field target conductor to the electrode 
lead, wherein the electrode lead acts to concentrate electromagnetic fields in 
the vicinity of the implant conductor assembly towards said at least one field 
target conductor.  
5 According to a further aspect of the present invention there is provided an 
implant conductor assembly substantially as described above wherein said at 
least one field target conductor is positioned with its longitudinal axis parallel 
to the longitudinal axis of the electrode lead, the longitudinal axis of said at 
least one field target conductor and the electrode lead being offset from 
o each other.  
The present invention is arranged to provide an implant conductor assembly 
for use in combination with surgical implant technology, and will be referred 
to in various embodiments to as providing part of a surgical implant.  
5 Reference in general will also be made throughout this specification to this 
implant conductor assembly being used with a bioelectrical stimulation 
implant. In these applications an implant conductor assembly can include an 
electrode lead formed from a length of conductive material which has one 
end defining an electrode and an opposite end defining a supply terminal.  
30 
Those skilled in the art will however appreciate that the implant conductor 
assembly provided by the invention may be used in other applications if 
required. In particular the invention may be used with implants which need 
not necessarily provide a bioelectrical stimulation effect nor provide an 
35 implant conductor with one end forming an electrode or alternatively a 
supply terminal.  
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Reference throughout this specification will also be made to an electrode 
lead provided with the invention being formed from an existing or prior art 
electrode lead. For example, in some embodiments an electrode lead may be 
5 formed from a structure which integrates a plurality of electrode conductors 
each being capable of performing as an electrode. In yet another 
embodiment an electrode lead may simply incorporate one such electrode 
conductor. The implant conductor assemblies provided by the invention 
incorporate one or more field target conductors to minimise or attenuate the 
10 induction of radio frequency electrical currents in such prior art electrode 
leads.  
A field target conductor employed with the invention is located adjacent to 
the electrode lead at a position which promotes mutual coupling of the 
15 electrode lead to the field target conductor. The adjacent positioning of the 
field target conductor offsets the longitudinal axis of the electrode lead from 
the longitudinal axis of the field target conductor.  
This may be contrasted with prior art implant conductor assemblies which 
2o employ a shield material wrapped around and enclosing an electrode 
conductor. With such prior art arrangements the longitudinal axis of the 
shield material is aligned with and therefore not offset from the longitudinal 
axis of the electrode lead. Conversely, with the present invention a field 
target conductor is positioned with its longitudinal axis parallel to the 
25 longitudinal axis of the electrode lead, each longitudinal axis being offset 
from the other.  
The adjacent positioning of the field target conductor to the electrode lead 
and the mutual coupling of these elements results in the electrode lead 
30 concentrating electromagnetic fields in the vicinity of the assembly towards 
the field target conductor. The electrode lead - which normally experiences 
detrimental induced radio frequency currents - operates in the invention to 
direct and reflect electromagnetic fields so that field intensity is experienced 
by the field target conductor at the expense of the electrode lead. This effect 
35 is achieved by tailoring the size, length or dimensions of any field target 
conductor relative to the form of the electrode lead provided by the 
invention. In practice the assembly provided by the invention may be 
4
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described in terms of electromagnetic field antenna terminology, where the 
electrode lead acts as a mutually-coupled element with the field shaped 
towards the field target conductor after the fashion of 'reflector' and 
'director' elements acting in a multi-element antenna.  
5 
In a preferred embodiment the length of a field target conductor may be less 
than the length of the electrode lead.  
In some embodiments this length differential may be as small as half the 
10 wavelength of the expected electromagnetic field to which the assembly is to 
be exposed.  
In various embodiments a range of field conductor lengths may be used. For 
example, in some embodiments a field target conductor can have a length in 
15 the range of 40% to 90% of the length of the electrode lead. In further 
embodiments a field target conductor may have a length in the range of 
50% to 70% of the length of the electrode lead, while yet in other preferred 
embodiments a field target conductor can have a length approximately equal 
to 60% of the length of the electrode lead. Those skilled in the art will 
2o appreciate that the length of the field target conductor used can vary to suit 
the required performance of the invention, the type or types of MRI scanner 
machines the assembly is to be exposed to and potentially the materials 
used to construct the conductor.  
25 Those skilled in the art will also appreciate that an implant conductor 
assembly provided by the invention may include only one field target 
conductor in some instances, while in other embodiments two or potentially 
more field target conductors may be provided adjacent to an electrode lead.  
30 For example, in one embodiment a single field target conductor may be 
located adjacent to one side of an electrode lead, and may preferably extend 
approximately 60% of the length of the electrode lead.  
In another embodiment a pair of field target conductors may be provided in 
35 conjunction with implant conductor lead assembly. In preferred 
embodiments of this form these two field target conductors can be located 
on opposite sides of the same electrode lead.  
5
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In such embodiments the pair of conductors can exhibit a range of lengths, 
and need not necessarily be of the same length. For example, in some 
instances these field target conductors may extend at least 40% of the 
5 length of the electrode lead, while in other embodiments they may exhibit 
lengths extending at least 60% of the length of the electrode lead. In yet 
other implementations one or both of this pair of field target conductors may 
extend approximately 90% of the length of the electrode lead.  
10 Again those skilled in the art will appreciate that the length of the field 
target conductors used can vary to suit the required performance of the 
invention, the type or types of MRI scanner machines the assembly is to be 
exposed to and potentially the materials used to construct the conductor.  
15 In yet other embodiments discrete linear arrays of relatively short field 
target conductors may be located adjacent to one side of an electrode lead, 
with multiple short conductors running the same length as an equivalent 
single long conductor. In further alternative embodiments multiple linear 
arrays of short field target conductors can be located on opposite sides of an 
2o electrode lead, with again the multiple short conductors running the same 
length as an equivalent single long conductor.  
Furthermore, in additional embodiments a field target conductor may be 
optimised to perform effectively when exposed to the emissions of one 
25 specific type of MRI scanning machine, or a set of two or more types of MRI 
machines operating at different frequencies. For example, in some 
embodiments an implant conductor assembly may include a set of one or 
more field target conductors optimised to mitigate heating effects when 
exposed to the field of a 1.5 T / 64 MHz MRI scanner, and can also include a 
30 second set of one or more field target conductors optimised to mitigate 
heating effects when exposed to the field of a 3 T / 128 MHz MRI scanner. In 
yet other embodiments an implant conductor assembly may be provided 
with one or more field target conductors optimised to mitigate heating 
effects when exposed to the fields of both 1.5 T / 64 MHz and 3 T / 128 MHz 
35 MRI scanners.  
6
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A field target conductor may be formed from materials currently employed 
as existing prior art implant conductors. In various embodiments the 
conductive material selected may exhibit desirable electrical characteristics 
while minimising patient tissue rejection or irritation effects.  
5 
In preferred embodiments a field target conductor may be formed from a 
length of conductive material. This conductor will therefore have a 
longitudinal length dimension which is substantially greater than its cross
section width. The field target conductor will define an exterior surface which 
10 extends between each end of the length of conductive material.  
Those skilled in the art will appreciate that various arrangements of 
conductive materials may be used to form lengths of field target conductor.  
In a range of embodiments a field target conductor may be formed by any 
15 arrangement of conductive components, such as a solid length of conductor, 
multi-stranded wire or alternatively woven conductive filaments or fibres. In 
various embodiments these filaments may have either a substantially solid 
or hollow cross section profile.  
20 In a preferred embodiment a field target conductor may exhibit a 
substantially uniform transverse cross-section profile along its entire length.  
Reference throughout this specification will also be made to the field target 
conductor being provided with this uniform character, although those skilled 
in the art will appreciate that other arrangements and physical dimensions 
25 are also within the scope of the invention.  
In a preferred embodiment at least a portion of the exterior surface of a field 
target conductor may be exposed to the body tissue of the recipient of the 
assembly.  
30 
For example, in one embodiment at least the mid-point or middle section of 
the length of the conductor is exposed to the body tissue of the implant 
recipient. Alternatively, in other embodiments substantially all of the exterior 
surface of the field target conductor may be exposed to the tissue of an 
35 implant recipient. However in yet other embodiments the ends of a field 
target conductor may be sealed inside an electrically insulating material.  
7
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In various embodiments the physical characteristics of the material used to 
provide a field target conductor may be optimised for its role as part of the 
surgical implant. In a preferred embodiment a field target conductor may be 
provided with an electrical resistance ranging from 10-100000 Ohms/meter.  
5 
In a preferred embodiment at least one field target conductor is formed of a 
material having increased electrical resistance such that the energy of an 
MRI field is dissipated substantially evenly throughout the at least one field 
target conductor.  
10 
For example, in various embodiments the material used to form such a 
conductor may be selected for relatively high electrical resistance - such as 
that provided by low conductivity metals or various composite materials 
which are still able to perform effectively as field target conductors. An 
15 increased electrical resistance allows the energy of an MRI field directed into 
a target field conductor to be dissipated evenly throughout its length as heat 
at temperatures which are unlikely to damage body tissues. A range of 
materials may be used in various embodiments to provide such electrical 
resistance improvements, including - but not limited to - gold, platinum, 
20 iridium, rhodium and their alloys, as well as silver cored wires, titanium, 
tungsten and/or stainless steel.  
In yet other embodiments the physical structure and/or electrical 
connections made by a field target conductor may be optimised to maximise 
25 the effective surface area of the conductor. In such embodiments it is 
preferable to maximise the exposure of the surface of a field target 
conductor to the tissue of an implant patient. Surface area increases 
improve the electrical coupling experienced between the field target 
conductor and these tissues, allowing energy absorbed by the target 
30 conductor to be dissipated into the surrounding patient tissues. Surface area 
increases may be produced by selecting a broad diameter target field 
conductor, roughening the surface of such a conductor, or potentially in 
some instances by connecting the end of the conductor furthest from the 
electrode of the implant to other internal implant components, such as an 
35 impulse generator housing.  
8
WO 2017/086805 PCT/NZ2016/050182 
The present invention may therefore provide potential advantages over the 
prior art or at least provide an alternative choice to the existing prior art.  
The invention adds at least one field target conductor to various forms of 
5 prior art implant electrode leads. The addition of a field target conductor 
therefore improves the resulting implant assembly without requiring any 
significant modifications to these prior art implant electrode leads.  
The invention can be used to mitigate the health risks associated with the 
10 exposure of surgical implants to strong electromagnetic fields. The implant 
conductor assembly provided by the invention can minimise the induction of 
radio frequency currents within an implant conductor electrode lead.  
The implant conductor assembly provided by the invention may be used with 
15 a wide variety of prior art implant conductor materials and may also provide 
safety advantages over a range of frequencies of alternating current. In 
particular the invention may safeguard surgical implant users from tissue 
heating and induced current effects in various situations ranging from 
exposure to MRI machines through to, for example, proximity to electrical 
20 welding machines or strong electromagnetic signal transmitters.  
Brief description of the drawings 
25 Additional and further aspects of the present invention will be apparent to 
the reader from the following description of embodiments, given by way of 
example only, with reference to the accompanying drawings in which: 
• Figure 1 provides a perspective view of one end of an implant lead 
30 assembly with a single field target conductor as provided in 
accordance with one embodiment of the invention.  
• Figure 2 provides a side cross section view through the assembly of 
figure 1 where marked at line A-A.  
35 
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• Figures 3a, b and c show midpoint cross-section views of the simulated 
magnitude of the magnetic field surrounding an insulated conductor in 
figure 3a, an electrode wire lead with single field target conductor in 
figure 3b, and an electrode wire lead flanked by two opposed field 
5 target conductors in figure 3c.  
• Figure 4 provides a perspective view of one end of an implant lead 
assembly with multiple field target conductors as provided in 
accordance with an alternative embodiment to that shown with respect 
10 to figures 1 and 2.  
• Figures 5a, 5b show heat generated plotted against various lengths of 
the lead when a single field target conductor is provided. Figure 5a 
shows temperature changes experienced at the distal electrode of the 
15 electrode lead when the electrode lead is adjacent to this single field 
target conductor. Figure 5b shows temperature changes experienced 
in the single field target conductor located adjacent to an electrode 
lead.  
20 * Figures 6a, 6b show heat generated plotted against various lengths of 
the lead when the electrode lead is adjacent to two opposed field 
target conductors. Figure 6a shows temperature changes experienced 
at the distal electrode of the electrode lead when the electrode lead is 
adjacent to these two opposed field target conductors. Figure 6b 
25 shows heat generated by one of the two field target conductors when 
the electrode lead is adjacent to these two opposed field target 
conductors.  
• Figures 7a, 7b show the temperature change of the distal electrode 
30 plotted against length of the electrode lead in the case of the single 
field target conductor arrangement of figure 5a.  
10
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• Figures 8a, 8b show the temperature change of the distal electrode 
plotted against length of the electrode lead in the case of the dual field 
target conductor arrangement of figure 6a.  
5 * Figure 9 shows a comparison of simulated predictions of heat 
generated at the distal electrode plotted against various lengths of the 
lead with differing diameter measurements.  
10 Further aspects of the invention will become apparent from the following 
description of the invention which is given by way of example only of 
particular embodiments.  
Best modes for carrying out the invention 
15 
Figure 1 provides a perspective view of one end of an implant lead assembly 
1 which incorporates a single field target conductor 2 in accordance with one 
embodiment of the invention. Figure 2 provides a side cross section view 
through the assembly 1 where marked at line A-A.  
20 
The implant conductor assembly 1 includes an electrode lead 3, and the 
single field target conductor 2 shown. The field target conductor 2 is located 
adjacent to the electrode lead 3 to mutually couple the field target conductor 
to the electrode lead. Surface portions 3a of the exterior of the electrode 
25 lead are coated in an electrical insulation jacket material, while exposed 
surface portions 3b form contact electrodes.  
As can be seen from figure 2 the field target conductor 2 is formed from a 
solid length of conductive metal wire. The electrode lead shown incorporates 
30 four electrode conductors 4 surrounded by the jacket of electrical insulator 
material 3a which retains each electrode conductor in place within the 
electrode lead structure. These conductors 4 are able to move to a limited 
degree inside the insulator jacket 3a. Each of the four electrode conductors 
are also coated with a layer of insulation 5. A stylet 6 is provided to guide 
35 the entire assembly into the body of a recipient. Once the assembly is 
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installed within a user the stylet is removed leaving a void in the interior of 
the electrode lead 3.  
The field target conductor 2 is located to one side of the electrode conductor, 
5 thereby providing a parallel offset orientation to the longitudinal axes of 
each of the field target conductor 2 and electrode lead 3. A layer of adhesive 
7 is used to locate the field target conductor 2 with its longitudinal axis 
parallel to the longitudinal axis of the electrode lead 3, where the 
longitudinal axis of each of the field target conductor and electrode lead are 
10 offset from each other.  
This positioning of the electrode lead 3 and the relative lengths of each 
conductor act to concentrate electromagnetic fields in the vicinity of the 
assembly 1 towards the field target conductor 2. This interaction between 
15 the field target conductor and electrode lead is shown in more detail with 
respect to figures 3a and 3b.  
Figures 3a, b and c show midpoint cross-section views of the simulated 
magnitude of the magnetic field surrounding an insulated electrode lead in 
20 figure 3a, an insulated electrode lead with single field target conductor in 
figure 3b and an insulated electrode lead flanked by two opposed field target 
conductors in figure 3c. In each of these plots the total length, I, of the 
insulated electrode lead is 25 cm. Figure 3b shows an insulated electrode 
lead with a single bare conductor 60% the length of the lead, while figure 3c 
25 shows two target field conductors which are 90% the length of the insulated 
electrode lead depicted.  
Figure 3a shows the magnetic field distribution for the electrode lead 3 in the 
absence of a field target conductor. As can be seen by this image the lead 3 
30 acts as an antenna to concentrate the field intensity about the longitudinal 
axis of the lead.  
Figure 3b shows the distribution of the same magnetic field when the field 
target conductor is located adjacent to the electrode lead. As can be seen 
35 from figure 3b the field has been shaped by the combination with the 
adjacent conductor, with the field target conductor experiencing the areas of 
highest intensity when compared to that experienced by the electrode lead.  
12
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Figure 3c shows the distribution of the same magnetic field when a pair of 
opposed field target conductors are located on opposite sides of the 
electrode lead. As can again be seen from figure 3c the field has been 
5 shaped by the combination of adjacent conductors, with the field target 
conductors experiencing the areas of highest intensity when compared to 
that experienced by the electrode lead.  
Figure 4 provides a perspective view of one end of an implant lead assembly 
10 11 with multiple field target conductors 12 provided in an alternative 
embodiment to that shown with respect to figures 1 and 2. The magnetic 
fields experienced by this form of assembly are discussed with respect to 
figure 3c.  
15 This alternative arrangement positions a pair of opposed field target 
conductors on either side of an electrode lead 13. The ends of each field 
target conductor are encapsulated by a plastic insulator material while the 
middle section of each conductor (not shown) is exposed to the body tissue 
of the recipient of the assembly.  
20 
In this embodiment each field target conductor has a length approximately 
90% that of the electrode lead, allowing the electrode lead to shape and 
reflect electromagnetic fields towards each field target conductor.  
25 Figures 5a, 5b show heat generated at the distal electrode plotted against 
various lengths of the lead when a single field target conductor is provided.  
Figure 5a shows temperature changes experienced at the distal electrode of 
the electrode lead when the electrode lead is adjacent to this single field 
target conductor. Figure 5b shows temperature changes experienced in the 
30 single field target conductor located adjacent to the electrode lead.  
Field target conductor lengths are varied from 0.3- 0.9 1 to produce the data 
plotted, where a standard lead without a field target conductor has the 
profile denoted by "none".  
35 
Fig. 5(a) shows simulated predictions of the distal heating for an assortment 
of electrode leads with length I, each having a single field target conductor of 
13
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specified fraction of this length. It is apparent a field target conductor of 
length 0.61-0.71 produces the least amount of heating over the range.  
The field target conductor itself experiences some heating along its length as 
5 is shown in Fig. 5(b).  
Figures 6a, 6b show heat generated plotted against various lengths of the 
lead when the electrode lead is adjacent to two opposed field target 
conductors. Figure 6a shows temperature changes experienced at the distal 
10 electrode of the electrode lead when the electrode lead is adjacent to these 
two opposed field target conductors. Figure 6b shows heat generated by one 
of the two field target conductors when the electrode lead is adjacent to 
these two opposed field target conductors.  
15 Field target conductor lengths are varied from 0.3- 0.91 to produce the data 
plotted, where a standard lead without a field target conductor has the 
profile denoted by "none". Distal heating is virtually eliminated for leads with 
two field target conductors as is shown Fig. 6(a), when the length of each 
equivalent field target conductor is between 0.71-0.9.  
20 
Figures 7a, 7b show the temperature change of the distal electrode plotted 
against length of the electrode lead in the case of the single field target 
conductor arrangement of figure 5a. The measured distal heating of 
electrode leads with a single 0.61 target conductor and a 0.91 target 
25 conductor are shown in Figs. 7(a) and 7(b),respectively.  
Figures 8a, 8b show the temperature change of the distal electrode plotted 
against length of the electrode lead in the case of the dual field target 
conductor arrangement of figure 6a. The measured distal heating of 
30 electrode leads with a 0.61 target conductor and a 0.91 target conductor are 
shown in Figs. 8(a) and 8(b), respectively.  
Fig. 8 shows an even greater reduction in distal heating when the same 
leads have a pair of opposed (and possibly identical) field target conductors.  
35 
Figure 9 shows a comparison of simulated predictions of heat generated at 
the distal electrode plotted against various lengths of the lead with differing 
14
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diameter measurements. This figure illustrates embodiments which include a 
single field target conductor with a length of either 0.61 or 0.91. The dashed 
line traces illustrate the heat increase for target conductors with diameters 
of 0.4mm, whereas the thicker variants have diameters of 0.8mm.As shown, 
5 the field target conductors with the larger diameters result in less distal 
heating.  
It is to be understood that the present invention is not limited to the 
embodiments described herein and further and additional embodiments 
1o within the spirit and scope of the invention will be apparent to the skilled 
reader from the examples illustrated with reference to the drawings. In 
particular, the invention may reside in any combination of features described 
herein, or may reside in alternative embodiments or combinations of these 
features with known equivalents to given features. Modifications and 
15 variations of the example embodiments of the invention discussed above will 
be apparent to those skilled in the art and may be made without departure 
of the scope of the invention as defined in the appended claims.  
15
What we claim is: 
1. An implant conductor lead assembly which includes an electrode lead 
5 comprising at least one length of conductive material, and at least one 
field target conductor located adjacent to the electrode lead such that 
a longitudinal axis of the or each field target conductor is offset from a 
longitudinal axis of the electrode lead, the at least one field target 
conductor being located to mutually couple the field target conductor 
0 to the electrode lead, 
wherein the electrode lead acts to concentrate electromagnetic fields 
in the vicinity of the implant conductor assembly towards said at least 
one field target conductor.  
s 2. An implant conductor lead assembly as claimed in claim 1 wherein at 
least one field target conductor is positioned with its longitudinal axis 
parallel to the longitudinal axis of the electrode lead.  
3. An implant conductor lead assembly as claimed in claim 1 wherein the 
o field target conductor is formed from multi-stranded wire.  
4. An implant conductor lead assembly as claimed in claim 1 wherein the 
length of a field target conductor is less than the length of the 
electrode lead.  
5 
5. An implant conductor lead assembly as claimed in claim 4 wherein the 
length difference is half the wavelength of the expected 
electromagnetic field of an MRI machine.  
30 6. An implant conductor lead assembly as claimed in claim 4 wherein a 
field target conductor has a length in the range of 40% to 90% of the 
length of the electrode lead.  
7. An implant conductor lead assembly as claimed in claim 6 wherein a 
35 field target conductor has a length in the range of 50% to 70% of the 
length of the electrode lead.  
16
8. An implant conductor lead assembly as claimed in claim 7 wherein a 
field target conductor has a length approximately equal to 60% of the 
length of the electrode lead.  
5 
9. An implant conductor lead assembly as claimed in claim 8 which 
includes a single field target conductor located adjacent to one side of 
the electrode lead and extending approximately 60% of the length of 
the electrode lead.  
0 
10. An implant conductor lead assembly as claimed in claim 4 which 
includes a pair of field target conductors.  
11. An implant conductor lead assembly as claimed in claim 10 wherein 
5 the field target conductors are located on opposite sides of the 
electrode lead.  
12. An implant conductor lead assembly as claimed in claim 10 or claim 
13, wherein the field target conductors each extend at least 40% of 
o the length of the electrode lead.  
13. An implant conductor lead assembly as claimed in claim 12 wherein 
the field target conductors each extend at least 60% of the length of 
the electrode lead.  
5 
14. An implant conductor lead assembly as claimed in claim 13 wherein 
the field target conductors each extend approximately 90% of the 
length of the electrode lead.  
30 15. An implant conductor lead assembly as claimed in claim 1 wherein at 
least one field target conductor is formed of a material having 
increased electrical resistance such that the energy of an MRI field is 
dissipated substantially evenly throughout the at least one field target 
conductor.  
35 
16. An implant conductor lead assembly as claimed in claim 1 which 
exhibits an electrical resistance ranging from 10-100000 Ohms/meter.  
17
17. An implant conductor lead assembly as claimed in claim 1 wherein the 
ends of a field target conductor are sealed inside an electrically 
insulating material.  
5 
18. An implant conductor lead assembly as claimed in claim 1 wherein at 
least a portion of the exterior surface of a field target conductor is 
exposed to the body tissue of the recipient of the assembly.  
o 19. An implant conductor lead assembly as claimed in claim 18 wherein 
substantially all of the exterior surface of the field target conductor is 
exposed to the tissue of an implant recipient.  
20. An implant conductor lead assembly as claimed in claim 18 wherein at 
5 least the mid-point of the length of the conductor is exposed to the 
body tissue of the implant recipient.  
21. A method of concentrating electromagnetic fields in a vicinity of an 
implant conductor lead assembly, the implant conductor lead 
o assembly including an electrode lead comprising at least one length 
of conductive material and at least one field target conductor located 
adjacent to the electrode lead, the method comprising: 
mutually coupling the field target conductor to the electrode lead 
by offsetting a longitudinal axis of the at least one field target 
5 conductor from a longitudinal axis of the electrode lead such that the 
field target conductor is spaced apart from the electrode lead, 
wherein the electrode lead acts to concentrate electromagnetic fields 
in the vicinity of the implant conductor lead assembly towards said at 
least one field target conductor.  
30 
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